AU2669501A - New use - Google Patents

New use

Info

Publication number
AU2669501A
AU2669501A AU26695/01A AU2669501A AU2669501A AU 2669501 A AU2669501 A AU 2669501A AU 26695/01 A AU26695/01 A AU 26695/01A AU 2669501 A AU2669501 A AU 2669501A AU 2669501 A AU2669501 A AU 2669501A
Authority
AU
Australia
Prior art keywords
new use
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26695/01A
Other languages
English (en)
Inventor
Stephen Dudley Holmes
Ceri John Lewis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9928329.3A external-priority patent/GB9928329D0/en
Priority claimed from GB0022572A external-priority patent/GB0022572D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2669501A publication Critical patent/AU2669501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU26695/01A 1999-11-30 2000-11-28 New use Abandoned AU2669501A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9928329 1999-11-30
GBGB9928329.3A GB9928329D0 (en) 1999-11-30 1999-11-30 New use
GB0022572 2000-09-14
GB0022572A GB0022572D0 (en) 2000-09-14 2000-09-14 New use
PCT/EP2000/011873 WO2001039793A2 (fr) 1999-11-30 2000-11-28 Nouvelle utilisation

Publications (1)

Publication Number Publication Date
AU2669501A true AU2669501A (en) 2001-06-12

Family

ID=26245000

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26695/01A Abandoned AU2669501A (en) 1999-11-30 2000-11-28 New use

Country Status (2)

Country Link
AU (1) AU2669501A (fr)
WO (1) WO2001039793A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003242512A1 (en) * 2002-07-11 2004-02-02 Sema Aps Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive disease
NO2355851T3 (fr) * 2008-11-10 2018-09-01
CN112390884B (zh) * 2019-04-09 2022-07-08 苏州大学 Semaphorin7A单克隆抗体及其在制备用于治疗炎症疾病药物方面的应用
WO2021112927A1 (fr) 2019-12-06 2021-06-10 Regeneron Pharmaceuticals, Inc. Compositions de protéines anti-vegf et procédés de production associés

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2291477A1 (fr) * 1997-05-19 1998-11-26 Genetics Institute, Inc. Semaphorine e d'origine humaine et polynucleotides codant cette semaphorine e
DE19729211C2 (de) * 1997-07-09 1999-04-22 Hoechst Marion Roussel De Gmbh Humanes Semaphorin L (H-Sema-L) und korrespondierende Semaphorine in anderen Spezies
WO1999038885A2 (fr) * 1998-01-30 1999-08-05 Smithkline Beecham Plc Nouveaux composes
AU2982799A (en) * 1998-03-03 1999-09-20 Zymogenetics Inc. Human semaphorin zsmf-7
ES2315011T3 (es) * 1998-05-14 2009-03-16 Immunex Corporation Polipeptidos de semaforina.

Also Published As

Publication number Publication date
WO2001039793A2 (fr) 2001-06-07
WO2001039793A3 (fr) 2001-11-29

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU4431000A (en) Novel use
AU5967600A (en) Candystraw
AU7514700A (en) Cyanopiperidines
AU4115400A (en) Short-circuiter
AU6335000A (en) Depthimeter
AU2023701A (en) Sketcher
AU6440900A (en) Homogentisate-dioxygenase
AU2804600A (en) Arylaminoalkylamides
AU2699800A (en) Organoceramics
AU6098300A (en) Follistatin-3
AU4916900A (en) Benzofuranylsulfonates
AU4561600A (en) Benzofuranylaminoalcohols
AUPQ078799A0 (en) New use
AU1901801A (en) Glucofuranoses
AU2669501A (en) New use
AU7303400A (en) Osseo-distractor
AU1915601A (en) Periotome
AU4435300A (en) Hula-hoop
AU7513400A (en) Hydantoin-racemase
AU2582200A (en) Windturbine
AUPQ462399A0 (en) New use
AU3158701A (en) New use
AU5416100A (en) Retinoscopes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase